SCI Abstract

search
+
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants
Determinants of thrombotic events remain uncertain in patients with atrial fibrillation treated with
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab
Glanzmann's Thrombasthenia (GT) is a rare hemorrhagic condition caused by a platelet surface recepto
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT Trial)
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT Trial)
Introduction Venous thromboembolism (VTE) remains a significant source of postinjury morbidity an
Epidemiological study of hereditary hemorrhagic disorders in Najaf province, Iraq
Epidemiological study of hereditary hemorrhagic disorders in Najaf province, Iraq
Hemophilia and Von Willbrand disease (VWD) are the most well known types of hereditary hemorrhagic d
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose
Introduction In the absence of a patient's last direct oral anticoagulant (DOAC) dose time, best
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease
aDepartment of Medicine, Division of Hematology/Oncology, University of Pittsburgh bHemophilia Center of West...
Comparison of bleeding and ischemic events with apixaban vs. rivaroxaban in triple antithrombotic therapy regimens
Comparison of bleeding and ischemic events with apixaban vs. rivaroxaban in triple antithrombotic therapy regimens
Objective To compare the risk of readmissions for major bleeding within one year between apixaban
Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma
Effects of frozen storage conditions and freezing rate on the stability of coagulation proteins in human plasma
Objectives Degradation of coagulation proteins in frozen plasma may influence assay results. The
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding
A 71-year-old female with heart failure who underwent left ventricular assist device (LVAD) placemen
The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A
The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A
Acquired hemophilia A (AHA) is a rare, life-threatening hemorrhagic disease caused by autoantibodies
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report
Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Correspondence to Mehran Kari...
Disseminated intravascular coagulation in acute leukemia patients
Disseminated intravascular coagulation in acute leukemia patients
Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan Correspondence to Tomoyuki Kawad...
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen
Inherited dysfibrinogenemias are molecular disorders of fibrinogen that affect fibrin polymerization
Resolution of cardiac surgical bleeding with the combination of 4-factor prothrombin complex concentrate and fresh frozen plasma following lack of response to fresh frozen plasma alone in a patient with severe factor XI deficiency
Resolution of cardiac surgical bleeding with the combination of 4-factor prothrombin complex concentrate and fresh frozen plasma following lack of response to fresh frozen plasma alone in a patient with severe factor XI deficiency
Factor XI deficiency is associated with a bleeding tendency in some patients. Factor XI helps to red
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency
Reports describing symptoms and treatment of patients with congenital factor VII (FVII) deficiency f
Chronic pain in haemophilia: assessment and analgesic treatment
Chronic pain in haemophilia: assessment and analgesic treatment
People with haemophilia tend to experience pain from an early age because of venipuncture and hemart
Orthopedic surgical procedures in people with hemophilia
Orthopedic surgical procedures in people with hemophilia
People with hemophilia tend to develop joint lesions secondary to the recurrent hemarthroses typical
Hematological treatment and prophylaxis in patients with and without inhibitors
Hematological treatment and prophylaxis in patients with and without inhibitors
This document focuses on the hematological treatment and prophylaxis that should be indicated in thr
Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products
Individualizing primary prophylaxis in patients with hemophilia A and B, adherence and new products
The purpose of prophylaxis in hemophilic patients is to prevent bleeding. The latest guidelines of t
Nonpharmacological treatment for coping with pain
Nonpharmacological treatment for coping with pain
Pain is one of the most common reasons for consultation and one of the most difficult tasks to handl
A contemporary approach to the musculoskeletal problems associated with hemophilia
A contemporary approach to the musculoskeletal problems associated with hemophilia
It is essential that joint bleeds be treated in a hematologically and orthopedically optimal manner
Disability and the social impact of hemophilia
Disability and the social impact of hemophilia
In addition to receiving the medical treatment they need, people with hemophilia or other coagulopat
Hemostatic cover in orthopedic surgery
Hemostatic cover in orthopedic surgery
Bleeding into joints, known as hemarthrosis, is the most common kind of bleeding experienced by pati
Obesity and physical exercise in hemophilia
Obesity and physical exercise in hemophilia
The new coagulation factors have made possible to increase the life expectancy of patients with hemo
Haemophilic arthropathy: basic protocols for clinical examination and imaging
Haemophilic arthropathy: basic protocols for clinical examination and imaging
In haemophilia, screening protocols in the prevention and treatment of common lesions still require
Foundations of hemophilia and epidemiology
Foundations of hemophilia and epidemiology
Hemophilia, a congenital coagulopathy characterized by a deficiency in coagulation factor VIII (hemo
Catastrophic antiphospholipid syndrome immediately after coronary angiography: the unexpected complication
Catastrophic antiphospholipid syndrome immediately after coronary angiography: the unexpected complication
A 44-year-old woman with obstetric antiphospholipid syndrome (APS) presented to our institution with
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism
Exposure to higher levels of steroid hormones, like that in pregnancy or during combined hormonal co
Addressing the haemophilia healthcare crisis amidst Taliban rule: a call to action
Addressing the haemophilia healthcare crisis amidst Taliban rule: a call to action
aMedical Research Center, Kateb University bAfghanistan National Charity Organization for Special Diseases (A...
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism
Objective Intra-abdominal venous thromboembolism is rare with heterogeneous management. We aim to
Load More
format_indent_increase